Results for tag: "Aubagio"

Aubagio is a central nervous system (CNS) drug used to treat multiple sclerosis (MS). It is an immunomodulator, meaning it works by modulating the immune system to reduce inflammation and slow the progression of MS. It is taken orally, usually once a day, and is available in tablet form. Aubagio is the first oral medication approved by the US Food and Drug Administration (FDA) for the treatment of MS. It is also approved in Europe and other countries. Aubagio is marketed by Sanofi, a French pharmaceutical company. Other companies in the CNS drug market include Biogen, Novartis, Merck, and Teva Pharmaceuticals. These companies produce a variety of drugs for the treatment of MS, including injectable medications, oral medications, and disease-modifying therapies. Show Less Read more